Please Wait.....
Report
NA Flow Cytometry Market - Industry Trends and Forecast to 2030
Market Report I 2023-03-01 I 222 Pages I Data Bridge Market Research
The North America flow cytometry market is projected to register a substantial CAGR of 12.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
North America Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (U.S., Canada and Mexico) - Industry Trends & Forecast to 2030
Some of the major factors contributing to the growth of North America flow cytometry are:
- Increase prevalence of chronic diseases
- Rising geriatric population
Market Players:
Some of the major players operating in the North America flow cytometry market are:
- Thermo Fisher Scientific Inc.
- BD
- Agilent Technologies, Inc.
- Nexcelom Bioscience LLC
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Miltenyi Biotec
- lter, Inc. (A subsidiary of Danaher Corporation)
- Cytek Biosciences
- bioMerieux SA
- Q2 Solutions (a Subsidiary of IQVIA)
- Cytonome/ST, LLC
- Merck KGaA
- Sony Biotechnology Inc.
- Cell Signaling Technology, Inc.
- NanoCellect Biomedical
- Apogee Flow Systems Ltd.
- Bay bioscience Co., Ltd.
- Stratedigm, Inc
- BioLegend, Inc.
- NeoGenomics Laboratories
- Enzo Biochem Inc.
- Union Biometrica, Inc.
- BennuBio Inc.
- ORLFO Technologies
- Elabscience Biotechnology Inc.
- Takara Bio Inc.
TABLE OF CONTENTS
1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.3 OVERVIEW OF THE NORTH AMERICA FLOW CYTOMETRY MARKET 38
1.4 LIMITATIONS 40
1.5 MARKETS COVERED 40
2 MARKET SEGMENTATION 43
2.1 MARKETS COVERED 43
2.2 GEOGRAPHICAL SCOPE 44
2.3 YEARS CONSIDERED FOR THE STUDY 45
2.4 CURRENCY AND PRICING 45
2.5 DBMR TRIPOD DATA VALIDATION MODEL 46
2.6 MULTIVARIATE MODELLING 49
2.7 PRODUCT SEGMENT LIFELINE CURVE 49
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 50
2.9 DBMR MARKET POSITION GRID 51
2.10 MARKET APPLICATION COVERAGE GRID 52
2.11 VENDOR SHARE ANALYSIS 53
2.12 SECONDARY SOURCES 54
2.13 ASSUMPTIONS 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 58
4.1 PORTER'S FIVE FORCES 59
4.2 PESTEL ANALYSIS 60
5 MARKET OVERVIEW 61
5.1 DRIVERS 63
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES 63
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 64
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 65
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES 67
5.2 RESTRAINTS 68
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 68
5.2.2 LIMITATIONS OF FLOW CYTOMETRY 69
5.2.3 LACK OF SKILLED PROFESSIONALS 70
5.3 OPPORTUNITIES 71
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 71
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 72
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 73
5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH 74
5.4 CHALLENGES 74
5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 74
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 75
6 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT 77
6.1 OVERVIEW 78
6.2 REAGENTS AND CONSUMABLES 81
6.2.1 DYE 82
6.2.2 ANTIBODIES 82
6.2.3 BEADS 82
6.2.4 OTHERS 82
6.3 FLOW CYTOMETRY INSTRUMENTS 82
6.3.1 CELL ANALYZERS 83
6.3.1.1 CELL ANALYZERS, BY TYPE 84
6.3.1.1.1 IMAGING FLOW CYTOMETERS 84
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 84
6.3.1.2 CELL ANALYZERS, BY MODALITY 84
6.3.1.2.1 BENCHTOP 84
6.3.1.2.2 STANDALONE 84
6.3.2 CELL SORTERS 85
6.3.2.1 BENCHTOP 85
6.3.2.2 STANDALONE 85
6.4 ACCESSORIES 85
6.4.1 FILTERS 86
6.4.2 DETECTORS 86
6.4.3 OTHERS 86
6.5 SERVICES 87
6.6 SOFTWARE 87
7 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY 89
7.1 OVERVIEW 90
7.2 CELL-BASED FLOW CYTOMETRY 94
7.3 BEAD-BASED FLOW CYTOMETRY 95
8 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION 96
8.1 OVERVIEW 97
8.2 RESEARCH APPLICATIONS 101
8.2.1 CELL CYCLE ANALYSIS 102
8.2.2 CELL SORTING/SCREENING 102
8.2.3 CELL TRANSFECTION/VIABILITY 102
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 103
8.2.4.1 DRUG DISCOVERY 103
8.2.4.2 STEM CELL RESEARCH 103
8.2.4.3 IN VITRO TOXICITY TESTING 103
8.2.5 IMMUNOLOGY 103
8.2.6 APOPTOSIS 103
8.2.7 CELL COUNTING 103
8.2.8 OTHERS 103
8.3 CLINICAL APPLICATIONS 104
8.3.1 HAEMATOLOGY 105
8.3.2 CANCER 105
8.3.3 IMMUNODEFICIENCY DISEASES 105
8.3.4 ORGAN TRANSPLANTATION 105
8.3.5 OTHER CLINICAL APPLICATION 105
8.4 INDUSTRIAL APPLICATIONS 105
9 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER 107
9.1 OVERVIEW 108
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 111
9.3 ACADEMIC & RESEARCH INSTITUTES 112
9.4 HOSPITALS 113
9.5 CLINICAL TESTING LABORATORIES 114
9.6 BLOOD BANK 115
9.7 OTHERS 116
10 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 117
10.1 OVERVIEW 118
10.2 RETAIL SALES 121
10.3 DIRECT TENDERS 122
11 NORTH AMERICA FLOW CYTOMETRY MARKET, BY GEOGRAPHY 123
11.1 NORTH AMERICA 124
11.1.1 U.S. 133
11.1.2 CANADA 137
11.1.3 MEXICO 141
12 NORTH AMERICA FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE 145
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 145
13 SWOT ANALYSIS 146
14 COMPANY PROFILE 147
14.1 THERMO FISHER SCIENTIFIC INC. 147
14.1.1 COMPANY SNAPSHOT 147
14.1.2 REVENUE ANALYSIS 148
14.1.3 COMPANY SHARE ANALYSIS 148
14.1.4 PRODUCT PORTFOLIO 149
14.1.5 RECENT DEVELOPMENTS 149
14.2 BD 151
14.2.1 COMPANY SNAPSHOT 151
14.2.2 REVENUE ANALYSIS 151
14.2.3 COMPANY SHARE ANALYSIS 152
14.2.4 PRODUCT PORTFOLIO 152
14.2.5 RECENT DEVELOPMENT 153
14.2.5.1 COLLABORATION 153
14.3 AGILENT TECHNOLOGIES, INC. 154
14.3.1 COMPANY SNAPSHOT 154
14.3.2 REVENUE ANALYSIS 154
14.3.3 COMPANY SHARE ANALYSIS 155
14.3.4 PRODUCT PORTFOLIO 155
14.3.5 RECENT DEVELOPMENTS 156
14.4 SARTORIUS AG 157
14.4.1 COMPANY SNAPSHOT 157
14.4.2 REVENUE ANALYSIS 157
14.4.3 COMPANY SHARE ANALYSIS 158
14.4.4 PRODUCT PORTFOLIO 158
14.4.5 RECENT DEVELOPMENT 159
14.5 NEXCELOM BIOSCIENCE LLC 160
14.5.1 COMPANY SNAPSHOT 160
14.5.2 PRODUCT PORTFOLIO 160
14.5.3 RECENT DEVELOPMENT 160
14.5.4 COMPANY SHARE ANALYSIS 161
14.6 APOGEE FLOW SYSTEMS LTD. 162
14.6.1 COMPANY SNAPSHOT 162
14.6.2 PRODUCT PORTFOLIO 162
14.6.3 RECENT DEVELOPMENT 162
14.7 BAY BIOSCIENCE CO., LTD. 163
14.7.1 COMPANY SNAPSHOT 163
14.7.2 PRODUCT PORTFOLIO 163
14.7.3 RECENT DEVELOPMENT 163
14.8 BIOMERIEUX 164
14.8.1 COMPANY SNAPSHOT 164
14.8.2 REVENUE ANALYSIS 165
14.8.3 PRODUCT PORTFOLIO 165
14.8.4 RECENT DEVELOPMENT 165
14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 166
14.9.1 COMPANY SNAPSHOT 166
14.9.2 REVENUE ANALYSIS 166
14.9.3 PRODUCT PORTFOLIO 167
14.9.4 RECENT DEVELOPMENTS 168
14.9.4.1 ACQUISITION 168
14.9.4.2 PRODUCT LAUNCH 168
14.10 BENNUBIO INC. 170
14.10.1 COMPANY SNAPSHOT 170
14.10.2 PRODUCT PORTFOLIO 170
14.10.3 RECENT DEVELOPMENT 170
14.11 BIOLEGEND, INC. 171
14.11.1 COMPANY SNAPSHOT 171
14.11.2 PRODUCT PORTFOLIO 171
14.11.3 RECENT DEVELOPMENT 173
14.12 BIO-RAD LABORATORIES, INC. 174
14.12.1 COMPANY SNAPSHOT 174
14.12.2 REVENUE ANALYSIS 174
14.12.3 PRODUCT PORTFOLIO 175
14.12.4 RECENT DEVELOPMENT 175
14.13 CELL SIGNALING TECHNOLOGY, INC. 176
14.13.1 COMPANY SNAPSHOT 176
14.13.2 PRODUCT PORTFOLIO 176
14.13.3 RECENT DEVELOPMENT 177
14.14 CELLKRAFT BIOTECH PVT. LTD 178
14.14.1 COMPANY SNAPSHOT 178
14.14.2 PRODUCT PORTFOLIO 178
14.14.3 RECENT DEVELOPMENT 179
14.15 CYTEK BIOSCIENCES 180
14.15.1 COMPANY SNAPSHOT 180
14.15.2 PRODUCT PORTFOLIO 180
14.15.3 RECENT DEVELOPMENTS 181
14.15.3.1 PRODUCT LAUNCH 181
14.15.3.2 ACQUISITION 182
14.16 CYTOBUOY B.V. 183
14.16.1 COMPANY SNAPSHOT 183
14.16.2 PRODUCT PORTFOLIO 183
14.16.3 RECENT DEVELOPMENT 183
14.17 CYTONOME/ST, LLC 184
14.17.1 COMPANY SNAPSHOT 184
14.17.2 PRODUCT PORTFOLIO 184
14.18 COHERENT CORP. 185
14.18.1 COMPANY SNAPSHOT 185
14.18.2 REVENUE ANALYSIS 185
14.18.3 PRODUCT PORTFOLIO 186
14.18.4 RECENT DEVELOPMENTS 186
14.18.4.1 Announcement 186
14.18.4.2 PRODUCT LAUNCH 186
14.18.4.3 AWARDS 187
14.18.5 RECENT DEVELOPMENT 187
14.19 ELABSCIENCE BIOTECHNOLOGY INC. 188
14.19.1 COMPANY SNAPSHOT 188
14.19.2 PRODUCT PORTFOLIO 188
14.19.3 RECENT DEVELOPMENT 189
14.20 ENZO BIOCHEM INC. 190
14.20.1 COMPANY SNAPSHOT 190
14.20.2 REVENUE ANALYSIS 191
14.20.3 PRODUCT PORTFOLIO 191
14.20.4 RECENT DEVELOPMENT 191
14.21 IKEDA SCIENTIFIC CO., LTD. 192
14.21.1 COMPANY SNAPSHOT 192
14.21.2 PRODUCT PORTFOLIO 192
14.21.3 RECENT DEVELOPMENT 193
14.22 MERCK KGAA 194
14.22.1 COMPANY SNAPSHOT 194
14.22.2 REVENUE ANALYSIS 194
14.22.3 PRODUCT PORTFOLIO 195
14.22.4 RECENT DEVELOPMENT 195
14.23 MILTENYI BIOTEC 196
14.23.1 COMPANY SNAPSHOT 196
14.23.2 PRODUCT PORTFOLIO 196
14.23.3 RECENT DEVELOPMENT 198
14.23.3.1 PRODUCT LAUNCH 198
14.24 NANOCELLECT BIOMEDICAL 199
14.24.1 COMPANY SNAPSHOT 199
14.24.2 PRODUCT PORTFOLIO 199
14.24.3 RECENT DEVELOPMENTS 199
14.25 NEOGENOMICS LABORATORIES 201
14.25.1 COMPANY SNAPSHOT 201
14.25.2 REVENUE ANALYSIS 201
14.25.3 PRODUCT PORTFOLIO 202
14.25.4 RECENT DEVELOPMENT 202
14.26 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 203
14.26.1 COMPANY SNAPSHOT 203
14.26.2 PRODUCT PORTFOLIO 203
14.26.3 RECENT DEVELOPMENTS 203
14.27 ORFLO TECHNOLOGIES 204
14.27.1 COMPANY SNAPSHOT 204
14.27.2 PRODUCT PORTFOLIO 204
14.27.3 RECENT DEVELOPMENT 204
14.28 Q2 SOLUTION 205
14.28.1 COMPANY SNAPSHOT 205
14.28.2 REVENUE ANALYSIS 205
14.28.3 SERVICE PORTFOLIO 206
14.28.4 RECENT DEVELOPMENT 206
14.29 SONY BIOTECHNOLOGY INC. 207
14.29.1 COMPANY SNAPSHOT 207
14.29.2 PRODUCT PORTFOLIO 207
14.29.3 RECENT DEVELOPMENT 209
14.30 STRATEDIGM, INC 211
14.30.1 COMPANY SNAPSHOT 211
14.30.2 PRODUCT PORTFOLIO 211
14.30.3 RECENT DEVELOPMENT 211
14.31 SYSMEX CORPORATION 212
14.31.1 COMPANY SNAPSHOT 212
14.31.2 REVENUE ANALYSIS 213
14.31.3 PRODUCT PORTFOLIO 213
14.31.4 RECENT DEVELOPMENT 213
14.32 TAKARA BIO INC. 215
14.32.1 COMPANY SNAPSHOT 215
14.32.2 REVENUE ANALYSIS 215
14.32.3 PRODUCT PORTFOLIO 216
14.32.4 RECENT DEVELOPMENTS 216
14.33 UNION BIOMETRICA, INC. 217
14.33.1 COMPANY SNAPSHOT 217
14.33.2 PRODUCT PORTFOLIO 217
14.33.3 RECENT DEVELOPMENT 217
15 QUESTIONNAIRE 219
16 RELATED REPORTS 222
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security